Our Theory of Change: Smarter, Faster Clinical Trials

Current state

Today, Clinical Trials are Slow, Costly, and Complex.


Traditional clinical trials are burdened by inefficiencies, high costs, and lengthy timelines, making it difficult for healthcare innovators to bring new treatments to patients quickly. The slow pace of research means new treatments can take years to reach those who need them most.
Step 1

Inputs

  • Data Integration, Technology Development & Adaptive Trial Designs

    Empiric invests in the development of cutting-edge automation technology, real-world evidence integration, and adaptive trial designs.
  • Strategic Partnerships & Expertise
    Collaborations with healthcare innovators, research institutions, patient communities and technology partners to co-develop and refine trial methodologies.
  • Funding & Reinvestment
    Funding and reinvestment in automation and continuous improvement cycles to drive further innovation and scalability.
Step 2

Outputs

  • Optimised Clinical Trial Processes

    Empiric produces smarter, faster, and more cost-effective clinical trial designs, reducing inefficiencies and meeting regulatory standards.
  • Enhanced Stakeholder Confidence
    Stakeholders, including patients, pharma, biotech, and health service organisations (HSO’s), gain confidence in adopting innovative trial designs, supported by measurable outcomes and data-driven insights.
Step 3

Intermediate Outcomes

  • Increased Adoption of Adaptive Trials
    Pharma and biotech companies, along with HSOs, increasingly adopt adaptive trials due to demonstrated success and reduced costs.
  • Improved Trial Success Rates
    Faster enrolment, real-time data analysis, and optimised trial processes lead to higher success rates in clinical trials, bringing treatments to market more rapidly.
Step 4

Long-Term Outcomes

  • Transformational Health Outcomes
    Life-changing treatments are delivered to patients more quickly, improving global health outcomes and quality of life.
  • Global Leadership in Clinical Trials
    Empiric and Australia emerge as global leaders in clinical trial      innovation, setting new standards and driving widespread adoption of smarter trials.
Step 5

Overall Impact

  • Revolutionised Clinical Research Landscape
    The clinical research industry becomes more efficient, accessible, and impactful, with trials seamlessly integrated into routine care, delivering life-changing treatments sooner.
  • Empowered Healthcare Innovators
    Researchers and healthcare providers are empowered to conduct more effective and inclusive research, unlocking the full potential of better healthcare for all.

Future vision

Tomorrow, Clinical Trials will be Fast, Accessible, and Integrated.
When Empiric's Theory of Change is realised, clinical trials will be streamlined, cost-effective, and rapidly delivered. Life-changing treatments will reach patients sooner, and the integration of adaptive trials into routine clinical care will become the norm. Healthcare innovators will be empowered to conduct more research, driving better health outcomes and transforming lives globally.